Table 2. Meta-analysis of the clinical characteristics of the high CALLY group vs. the low CALLY group.
| Characteristics | No. of study | H (n=) | L (n=) | Heterogeneity (I2 %) | Modle | Meta-analysis | ||
|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | P value | ||||||
| Sex (Male/Female) | 6 | 1,064 | 1,033 | 0 | Fixed | 0.75 | 0.60–0.95 | 0.01 |
| Differentiation (Well/Not well) | 2 | 523 | 452 | 0 | Fixed | 1.08 | 0.81–1.43 | 0.60 |
| Neoadjuvant therapy (Yes/No) | 2 | 444 | 393 | 0 | Fixed | 1.45 | 0.97–2.16 | 0.07 |
| T status (T1/Not T1) | 4 | 750 | 511 | 0 | Fixed | 1.73 | 1.31–2.28 | 0.0003 |
| Lymph node metastasis(P /N) | 4 | 750 | 511 | 12 | Fixed | 0.85 | 0.67–1.08 | 0.08 |
| Vessel invasion (P /N) | 4 | 773 | 522 | 0 | Fixed | 0.73 | 0.57–0.93 | 0.03 |
| TNM stage (I/Not I) | 4 | 624 | 636 | 0 | Fixed | 1.61 | 1.20–2.17 | 0.0006 |
| Postoperative complication (Yes/No) | 2 | 239 | 459 | 95 | Random | 2.81 | 0.30–26.29 | 0.36 |
Notes.
- H
- High CALLY group
- L
- Low CALLY group
- n
- Number of patients
- P
- positive
- N
- negative
- D
- Differentiated
- U
- Undifferentiated
- SCC
- Squamous cell carcinoma